大黄附子汤联合常规西药治疗重症脓毒症临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R459.7

基金项目:


Clinical Study on Dahuang Fuzi Tang Combined with Conventional Western Medicine for Severe Sepsis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察大黄附子汤联合常规西药治疗重症脓毒症的疗效及对患者胃肠功能的影响。方法:选取重症脓毒症患者70 例,按随机数字表法分为对照组和观察组各35 例。对照组给予常规西医治疗,观察组在对照组基础上予以大黄附子汤治疗,共治疗7 d。评价2 组临床疗效,比较2 组治疗前后重症患者急性胃肠损伤分级(AGI)、胃肠功能障碍和急性生理与慢性健康评分表(APACHE Ⅱ) 评分、炎症因子水平及不良反应发生率。结果:观察组总有效率为91.43%,对照组为77.14%,2 组比较,差异无统计学意义(P>0.05)。治疗后,观察组AGI 分级情况优于对照组,差异有统计学意义(P<0.05)。治疗后,2 组胃肠功能障碍评分、APACHE Ⅱ评分较治疗前降低(P<0.05),且观察组胃肠功能障碍评分、APACHE Ⅱ评分低于对照组(P<0.05)。治疗后,2 组白细胞计数(WBC)、超敏C-反应蛋白(hs-CRP) 及降钙素原(PCT) 水平较治疗前降低(P<0.05),且观察组WBC、hs-CRP 及PCT 水平低于对照组(P<0.05)。2 组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:大黄附子汤联合西医常规治疗可提高重症脓毒症的临床疗效,有效缓解患者的胃肠功能障碍,并减轻机体的炎症反应,且无不良反应增加。

    Abstract:

    Abstract: Objective: To observe the effect of the therapy of Dahuang Fuzi Tang combined with conventional western medicine on patients with severe sepsis and its influence on gastrointestinal function. Methods: Seventy patients with severe sepsis were selected and divided into the control group and the observation group according to the random number table method,with 35 cases in each group. The control group was treated with conventional western medicine,and the observation group was additionally treated with Dahuang Fuzi Tang based on the treatment of the control group. The treatment lasted for seven days. The clinical effects in the two groups were evaluated. The grading of Acute Gastrointestinal Injury(AGI),the scores of Acute Physiology And Chronic Health Evaluation(APACHE Ⅱ), the levels of inflammatory indicators and the incidence of adverse reactions were compared between the two groups before and after treatment. Results: The total effective rate was 91.43% in the observation group, and 77.14% in the control group,there being no significant difference between the two groups(P>0.05). After treatment,the grading of AGI in the observation group was better than that in the control group, the difference being significant(P<0.05). After treatment,the scores of gastrointestinal dysfunction and APACHEⅡ in the two groups were decreased when compared with those before treatment(P<0.05),and the above scores in the observation group were lower than those in the control group(P<0.05). After treatment,the levels of white blood cell count(WBC), high- sensitivity C- reactive protein(hs- CRP) and procalcitonin(PCT) in the two groups were decreased when compared with those before treatment(P<0.05), and the levels of WBC, hs-CRP and PCT in the observation group were lower than those in the control group(P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05). Conclusion:The therapy of Dahuang Fuzi Tang combined with conventional western medicine can improve the clinical effect on severe sepsis, effectively alleviate gastrointestinal dysfunction, and reduce the body's inflammatory responses,without increasing adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文

刘志勇,蒋建强,毛萍萍,张静.大黄附子汤联合常规西药治疗重症脓毒症临床研究[J].新中医,2022,54(23):34-38

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-12-11
  • 出版日期:
文章二维码